ABSTRACT We examined whether or not subsets of patients with extension of myocardial infarct were at high risk for early and late mortality. Some data suggest increased risk in patients with non-Q wave infarcts and we hypothesized that infarct extension in this group might be associated with a poorer prognosis than that for patients with extension of Q wave infarcts. A total of 1253 patients with acute myocardial infarction who were included in our data base were followed prospectively. The patients were classified according to electrocardiographic results into the following groups: those with non-Q wave (n = 277) infarcts and those with Q-anterior (n = 462) and Q-inferior (n = 497) infarcts. Extension was diagnosed by two of the following criteria: (1) recurrent chest pain 24 hr or more after admission to the hospital, (2) new persistent electrocardiographic changes, and (3) elevation or reappearance of creatine kinase. By these criteria 85 (6%) patients had extension (8% of non-Q wave infarcts, 6% of Q-anterior infarcts, and 6% of Q-inferior infarcts). Hospital mortality in patients with extension was 15% in those with Q wave infarcts vs 43% in those with non-Q wave infarcts (p < .01). Nine hundred and fifty-two patients were followed for 1 year. In 24% of those who did not survive 1 year there was extension of infarct; only 6% of survivors had extension (p < .01). The 1 year cumulative survival rates for patients with Q wave vs non-Q wave infarcts with no extension were nearly identical: 82% and 84%. For patients with extension, 1 year survival rates for those with Q wave vs non-Q wave infarction were 66% and 35% (p < .01). In hospital survivors of non-Q wave infarction, death occurred twice as early with extension as without (70 ± 18 vs 168 + 28 days, p < .01). Of 60 variables examined for prognostic significance, extension was not a predictor in patients with Q wave infarcts but was the strongest univariate predictor of 1 year mortality in those with non-Q wave infarcts (p < .001). Thus, patients with non-Q wave infarction with extension represent a subset of patients at high risk for early and late mortality. Circulation 71, No. 2, 211-217, 1985. THE FREQUENCY of extension of myocardial infarct and its relationship to both short-and long-term prognosis is poorly defined. The reported incidence of infarct extension ranges from 9% to 86%. 
THE FREQUENCY of extension of myocardial infarct and its relationship to both short-and long-term prognosis is poorly defined. The reported incidence of infarct extension ranges from 9% to 86%.1. 2 Fraker et al.l estimated a rate of 11% to 17% on the basis of clinical findings in 797 episodes of acute myocardial infarction, whereas Reid et al. ,2 who used the criterium of reelevation of electrocardiographic ST segments during ST segment mapping, reported an 86% inci-dence of infarct extension in 19 patients with anterior infarction. Mathey et al. 3 found that abnormal serum creatine kinase (CK) release curves were present in 62% of 40 patients with infarcts. In a postmortem study, Hutchins and Bulkley4 examined hearts from 76 patients with clinically diagnosed and histologically proven infarctions and found that 13% had foci of recent necrosis around the infarction.
Because of the limited numbers of patients in prospective studies, as well as variable criteria for diagnosing infarct extension, it has been difficult to define subsets of patients with extension who might be at high risk for early and late mortality. Non-Q wave infarctions are generally associated with less necrosis and a low initial mortality when compared with Q wave infarcts,5 6 but despite this initially favorable prognosis, evidence has accumulated that long-term mortality in patients with non-Q wave infarctions is similar to or even greater than that in patients with Q wave infarctions. 7 8 Recently it has been shown that non-Q wave infarcts result in a higher incidence of patent vessels than Q wave infarcts,9 suggesting the potential for an unstable setting. It was our hypothesis that patients with non-Q wave infarcts who have extension of myocardial infarction while in the hospital may represent a subset of patients who are at higher risk than patients with Q wave infarction who undergo extension. Although non-Q wave and Q wave infarcts as classified by electrocardiographic results cannot always be anatomically differentiated, it seems likely that they differ clinically and prognostically.
Methods
Patients. The study group consisted of 1253 patients with acute myocardial infarction. All patients were admitted to the hospital within 24 hr after onset of symptoms. Of the 1228 patients discharged from the hospital, 952 had been followed for 1 year at the time of this study. This group was analyzed for late mortality. The diagnosis of Q wave infarction was established by electrocardiographic changes with development of Q waves and at least one of the following: (1) chest pain considered characteristic of myocardial ischemia and (2) elevation of total CK level. Q waves acceptable for diagnosis were (1) anterior: Q wave of 0.04 sec or more in any precordial lead, (2) posterior: initial R wave in lead V1 2 of 0.04 sec duration with an R/S ratio of 1, (3) inferior: Q wave in lead Ill and aVF of 0.04 sec or more or of 25% of R wave in depth, and (4) lateral: Q wave in lead I, aVL of 0.04 sec or more and of 25% of amplitude of the R wave in either lead. Q wave anterior infarcts included anterior-septal and anterior-lateral infarctions and Q wave inferior infarctions included inferior-posterior and inferior-lateral infarctions. The diagnosis of non-Q wave infarction was established by chest pain, elevation of CK-MB level, and electrocardiographic criteria as follows: (1) persistent new T wave inversion and/or ST segment depression, (2) absence of new pathologic Q waves, and (3) no significant loss of R force. Infarct extension was defined by the presence of at least two of the following: (1) recurrent ischemic chest pain in the hospital more than 24 hr after admission, (2) increase in total serum CK level of at least 20% over the last abnormal value or of 100% over the last normal value, and (3) heart failure, typical angina pectoris, chronic obstructive pulmonary disease, hypertension, bundle branch block, and new or changing angina within 1 month before admission. In the intensive care unit, the following clinical parameters were assessed: maximal heart rate, minimum systolic blood pressure, maximal respiratory rate, the presence of S3 gallop, systolic murmur, apex impulse to the left of the midclavicular line, the presence and extent of rales, peripheral or sacral edema, and mental confusion. From chest radiographs, the maximal degree of pulmonary venous congestion was graded (0 to 4) as previously described.'3 Laboratory findings included maximal levels of CK, leukocytes, creatinine, and BUN. From the electrocardiogram the maximal measured QRS duration, maximal PR interval, and presence or absence of arrhythmias and conduction disturbances were determined. When patients were discharged it was noted whether they were taking digitalis, diuretics, procainamide, quinidine, or /3-blocking agents. The cardiothoracic ratio and degree of pulmonary congestion was measured on the chest radiograph obtained at discharge from the hospital.
In a subgroup of 496 patients left ventricular ejection fraction was measured by radionuclide techniques or cardiac catheterization before discharge. In another subgroup of 558 patients data from 24 hr ambulatory electrocardiographic monitoring before discharge were available. The presence or absence of complex ventricular arrhythmias, defined as frequent ventricular beats (more than 1 beat/min or 30 beats/hr), multiform ventricular premature beats, couplets, early premature beats, or ventricular tachycardia (3 beats with heart rate-1 00/min), was also determined.
Follow-up. All patients were followed up by telephone at 3, 6, and 12 months after hospital discharge. Information about deaths was obtained from death certificates, hospital records, or telephone interviews with the personal physician or family members. Only cardiac deaths were included in the analyses. Follow-up was more than 98% complete at 1 year.
Statistical methods. Univariate statistical analyses by chisquare test for discrete variables or t tests for continuous variables were used to assess differences in characteristics between patients with and without infarct extension and to study the influence of these variables on prognosis. To evaluate the independent importance of prognostic variables, the stepwise linear discrimination model (P7M) available in the Biomedical Computer Programs package of statistical programs was used. 14 Survival curves for the different populations were compared with the Mantel-Cox statistic as calculated by the survival function program (PIL) provided in the same software package.
Results
The characteristics of patients with Q wave vs those of patients with non-Q wave infarctions are presented in table 1. Among the 1253 patients studied (964 men and 289 women, mean ± SD age 63 ± 12 years) the type of infarction was classified as Q wave in 71 % (anterior 34%, inferior 37%), non-Q wave in 20%, and indeterminate in 9%. The overall hospital mortality was 9% and was similar in patients with Q wave and those with non-Q wave infarctions (10% and 8%, respectively). Eighty-five patients (6%) had infarct extension, and 62 of these were followed for 1 year.
There was a 6% incidence of extension in both the anterior and inferior Q wave groups (58 patients), and an 8% (23 patients) incidence in the non-Q wave group. The overall hospital mortality among the 85 patients who experienced extension of myocardial infarct was 18%. When extension occurred in those with non-Q wave infarctions, the hospital mortality was 43% compared with 15% when extension occurred in those with Q wave infarctions (p < .01). There was a higher prevalence of previous heart failure (20% vs 7%, p < .05), angina pectoris (56% vs 33%, p < .05), and infarction (44% vs 23%, p < .05) in the non-Q wave vs Q wave infarction groups. Sixty-two patients with infarct extension were followed for 1 year. In those who survived 1 year with non-Q wave infarctions, extension was present in 4% (figure 1), while in those who did not survive 1 year, extension had occurred in 24% (p < .01). No such difference between survivors and nonsurvivors with respect to infarct extension was seen in the anterior or the inferior Q wave group.
The cumulative survival curves beginning 24 hr after hospital admission for patients with Q wave and non-Q wave infarctions with and without extension are shown in figure 2. In patients with no extension, the survival curves for patients with Q wave and non-Q wave infarcts were not significantly different, with a 1 year mortalilty of 18% for the Q wave group and of 16% for the non-Q wave group. However, when survival was compared in patients with infarct extension, there was a highly significant difference. The cumulative survival at 1 year for patients with non-Q wave infarcts with extension was 35%, compared with 66% for those with Q wave infarctions with extension (p < .01). In the non-Q wave infarction group, the 1 sion compared with 84% in those without extension (p < .001). Among hospital survivors of non-Q wave infarcts, the time to death was shorter in the group with extension compared with the group without extension (70 + 18 vs 168 ± 28 days, p < .01). All deaths during the first year in the extension group occurred before day 150, whereas deaths in the group with no extension occurred throughout the first year.
Predictors of mortality. Table 2 lists univariate predictors of 1 The most important predictors for the non-Q wave infarction group were infarct extension, pulmonary congestion, and maximal BUN. Seventy-six percent of the patients with non-Q wave infarcts were correctly classified (57% of deaths and 80% of survivors). The most important predictors for the Q wave infarction group were maximal heart rate, S3 gallop at hospital discharge, age, and history of previous myocardial infarction. By these criteria, 75% of the patients with Q wave infarcts were correctly classified (49% of deaths and 78% of survivors).
Discussion
Prevalence of extension of infarct. The incidence of extension of myocardial infarct in the present study was 6%. The wide variation in the reported incidence of extension undoubtedly reflects differences in patient populations but, more importantly, it also indicates differences in the definitions of extension and the diagr nostic methods used to verify the extension. Our rather strict definition requires fulfillment of at least two of three criteria: (1) chest pain 24 hr or more after admission but before discharge from the hospital, (2) statistics suggest that this definition gives important prognostic information. Clinical significance of extension. The detection and diagnosis of extension of myocardial infarct is clinically important, as evidenced by higher in-hospital mortality of 18% in patients with extension compared with 7% in patients without extension (p < .05). This is in accordance with observations made by others. Buda et al."7 found a 16% in-hospital mortality in patients with infarct extension compared with a rate of 2.8% in those without extension. Fraker et al. ' found an in-hospital mortality of 36% (n -58) in those with extension as compared with 9% (n = 400) in patients without extension. Few studies have examined infarct extension relative to long-term survival. Marmor et al. '9 found that in-hospital mortality in patients with non-Q wave infarcts was greater in those with extension as defined by an increase in MB-CK level (23% vs 8%, p < .05), but at follow-up the 9 month mortality was not significantly different (34% vs 23%). This is in contrast to the present study (figure 2), in which mortality for patients with non-Q wave infarcts and extension was significantly greater at 1 year than for those with no extension (65% vs 16%, p < .01). It is possible that in the Marmor study the trend toward a higher 9 month mortality in patients with extension would have reached statistical significance with a larger number of patients. Another difference between the two studies is reflected in the survival rates of those with Q wave vs those with non-Q wave infarction with and without extension. In the present study the survival curves for patients with Q wave and non-Q wave infarcts were similar up to 1 year when no extension was present. However, when extension was present, the 1 year mortality for the group with non-Q wave infarcts was 65% vs 33% for the group with Q wave infarcts (p < .01). Again, this is in contrast to the results of Marmor et al.,19 who found the pattern of mortality to be identical for patients with non-Q wave infarcts and extension and those with Q wave infarctions and no extension. Thus, despite a low incidence of extension, the present study illustrates a high mortality, both early and late, for individuals with non-Q wave infarcts with extension.
Clinical variables associated with extension of non-Q wave infarctions. Marmor et al.,20 using a multiple logistic regression analysis of data from 200 patients, found that 80% of extensions could be predicted by the variables of non-Q wave infarction, obesity, female gender, and recurrent chest pain. Of these variables, only recurrent chest pain was associated with an increased incidence of extension in the present study.
The reasons for these differences are not clear, but are most likely related to patient selection criteria; Marmor's study included only those patients with reelevation of MB-CK levels. For the multivariate analysis of predictors of mortality after Q wave and non-Q wave infarction (table 3) , only patients with a complete clinical data base were used.
Unfortunately, data on ambulatory monitoring and ejection fractions were not available in all of our patients and were not used in the multivariate analysis. They were used in the univariate analysis, however. The selection of patients having these measurements appeared to be random because the incidence of varibles was similar to that in the entire group of patients. Nevertheless, we cannot rule out that some selection bias took place.
Explanation of poorer prognosis for patients with non-Q wave infarcts with extension. The terms transmural and subendocardial have been used for many years in the electrocardiographic classification of myocardial infarctions. Although the newer terms Q wave and non-Q wave more accurately depict the electrocardiographic event, there nevertheless exists a poor correlation between these and pathologic findings.8 10 An infarction without Q waves on the electrocardiogram may be nontransmural at postmortem examination, and non-Q wave infarcts may be transmural.2' Nevertheless, there is much evidence that Q wave and non-Q wave infarcts differ clinically, physiologically, and prognostically, as recently discussed by Spodick.) Non-Q wave infarcts are, in general, associated with a modest amount of necrosis and a low initial mortality compared with Q wave infarcts. Despite the initial favorable prognosis, prospective follow-up of our patients has confirmed previous reports that the 1 to 2 year mortality of patients with non-Q wave infarcts is similar to, and possibly greater than, that of patients with Q wave infarcts. 8 The mechanisms of late death in those with non-Q wave infarctions is not known. Schultz examined angiographic findings in 31 patients with Q wave and 17 patients with non-Q wave infarctions.f There was no difference between groups with respect to the prevalence of single-, double-, or triple-vessel disease. Connelly et al.9 looked at the incidence of collateral circulation in 63 patients with non-Q wave infarctions and compared it with that in 73 patients with Q wave infarction. A completely occluded vessel proximal to the infarcted area was present in 48% of non-Q wave and 79% of Q wave infarction patients. The distal segments of occluded vessels were supplied by collateral vessels in 93% of patients with non-Q wave infarcts and in 35% of patients with 216 Q wave infarcts. Thus, it appears that the anatomic distribution of coronary artery disease in those with non-Q wave infarct resembles that in patients with Q wave infarcts, but that viable amounts of myocardium may be protected from infarction by the presence of a subtotal coronary occlusion or collateral blood flow. Extension may be a sign that these areas of collateralized flow have become jeopardized.
It should also be noted that patients with non-Q wave infarctions have a significantly higher incidence of previous heart failure and infarction than those with Q wave infarctions. Although these variables are not associated with a higher incidence of extension per se, they seem likely to influence the outcome once extension occurs.
Implications and possible therapeutic interventions. It appears that patients with non-Q wave infarctions enter the hospital with more preexisting heart disease and undergo a somewhat smaller and incomplete infarction that is related to an atherosclerotic but patent vessel. If there is no extension of their infarctions, they may end up with cardiac impairment similar to that in patients with Q wave infarctions. The presence of extension, however, places these patients in a different category, since they are then at higher risk for both earlv and late mortality. Interventions in this regard could be aimed at two fronts. First, it is those patients with non-Q wave infarctions, who are at high risk of extension, in whom trials with drugs for preventing extension or preserving myocardium might be most beneficial. Once extension occurs in these patients, prolonged, careful monitoring in the hospital along with early treadmill testing or cardiac catheterization may be indicated. Further studies will be needed to establish the value of such strategies.
